MYCOF OTC
Noveris Health Sciences Inc.
1W: +0.0%
1M: +0.0%
3M: -63.5%
YTD: +234.9%
1Y: +12066.7%
3Y: +350.6%
5Y: +96.8%
$0.73
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$37K
+99.1% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$37K
+99.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$37K
-240.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$27M | -$24M | -$17M | -$21M | -$3M |
| Depreciation & Amort. | $90K | $235K | $129K | $10K | $0 |
| Stock-Based Comp. | $2M | $3M | $0 | $0 | $0 |
| Change in Working Capital | $2M | -$5M | $8M | $5M | $212K |
| Other Non-Cash Items | $11M | $309K | $474K | $11M | $3M |
| Operating Cash Flow | -$7M | -$24M | -$8M | -$4M | -$37K |
| — Investing Activities — | |||||
| Capital Expenditures | -$525K | -$404K | -$35K | $0 | $0 |
| Acquisitions (Net) | $504K | $0 | -$2K | $0 | $0 |
| Investment Purchases | -$314K | -$69K | $0 | $0 | $0 |
| Investment Sales | $314K | $0 | $0 | $0 | $0 |
| Other Investing | -$552K | $0 | $0 | $525K | $0 |
| Investing Cash Flow | -$573K | -$474K | -$38K | $525K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $5M | $6M | $73K | $110K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $633K | $3M | $0 | $0 | $0 |
| Financing Cash Flow | $10M | $24M | $7M | $4M | $0 |
| Net Change in Cash | $2M | -$695K | -$1M | $27K | -$37K |
| Cash End of Period | $2M | $1M | $11K | $38K | $325 |
| Free Cash Flow | -$8M | -$24M | -$8M | -$4M | -$37K |